Last updated: 2026-02-23 22:19:15 ET
Arcellx’s stock is heading toward a record after the $7.8 billion deal to be acquired by Gilead.
Robert F. Kennedy Jr. has criticized the broadening use of anxiety medications, but doctors and researchers say the MAHA movement is misrepresenting d...
Alabama Attorney General Stephen Marshall is leading a coalition of 20 states demanding the American Medical Association halt its support of hormonal ...
Vermont couple reached a settlement after their foster license was revoked for voicing reservations about transgender treatments for children in state...
Shares of Japan's Sumitomo Pharma fell over 12% on the back of profit-taking after a specialist panel endorsed its iPS cell-based therapy for Parkinso...
Abandoned beaches, public health warning signs and seagulls eating human waste are now features of the popular coastline in New ZealandA tide of anger...
The PD-1 and PD-L1 inhibitors market offers significant opportunities by expanding cancer treatment options using immunotherapy. Key developments incl...
The atopic dermatitis market offers opportunities in developing new and innovative therapies, with over 100 companies and 110 drugs in various stages ...
Opportunities in the Sickle Cell Disease market include advancing gene-editing therapies like EDIT-301, expanding VOC-reducing treatments such as incl...
The rheumatoid arthritis market is poised for growth due to the rising adoption of advanced disease-modifying therapies, fostering deeper patient rete...
